Literature DB >> 2650931

An adrenal cyst associated with 19-nor-deoxycorticosterone excess and low renin hypertension.

G T Griffing1, A V Chobainian, R Egdahl, M E Ehlers, J C Melby.   

Abstract

Adrenal cysts are rare, but they have been disproportionately associated with hypertension. This report describes a hypertensive patient with increased levels of 19-nor-deoxycorticosterone (19-nor-DOC), a potent mineralocorticoid. The patient was a thirty year old man with hypokalemia, moderately severe hypertension, suppressed PRA, and low aldosterone secretion. Following surgical removal of a 10 cm adrenal cyst, the hypertension improved, the hypokalemia resolved, and the PRA and the aldosterone secretion normalized. Urinary 19-nor-DOC pre-op was elevated 4.6 microgram per day (normal less than 1.0 microgram/day and subsequently became normal at 0.7 microgram per day following surgery. The adrenal cyst was a fibrous walled structure containing mucinous straw-colored fluid. Pericystic adrenocortical tissue demonstrated increased 19-OH-DOC production (a 19-nor-DOC precursor) which may have been responsible for the 19-nor-DOC excess. We hypothesize that compressive adrenal damage from the cyst may produce a form of adrenal regeneration hypertension which is known to be associated with 19-nor-DOC excess.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2650931     DOI: 10.3109/10641968909035344

Source DB:  PubMed          Journal:  Clin Exp Hypertens A        ISSN: 0730-0077


  2 in total

Review 1.  Adrenal cystic lesions: report of 12 surgically treated cases and review of the literature.

Authors:  R Bellantone; A Ferrante; M Raffaelli; M Boscherini; C P Lombardi; F Crucitti
Journal:  J Endocrinol Invest       Date:  1998-02       Impact factor: 4.256

2.  Comparative analysis of plasma 17-hydroxyprogesterone and cortisol responses to ACTH in patients with various adrenal tumors before and after unilateral adrenalectomy.

Authors:  M Tóth; K Rácz; V Adleff; I Varga; L Fütö; C Jakab; K Karlinger; R Kiss; E Gláz
Journal:  J Endocrinol Invest       Date:  2000-05       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.